Chronic kidney disease in patients with impaired thyroid function


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The prevalence of chronic kidney disease (CKD) is increasing worldwide, reaching epidemic levels. it is known that hyper-and hypofunction of the thyroid gland (TG) can be associated with the development of cardiorenal disorders and lead to a significant worsening of the prognosis in these patients. however, there is evidence that thyroid dysfunction is associated with the development and progression of ckd. the article discusses the issues of epidemiology and pathogenesis of renal dysfunction in patients with thyroid dysfunction. it has been shown that thyroid hormones can have a significant effect on renal function; therefore, it is important to take into account the physiological relationship between thyroid dysfunction and ckd.

全文:

受限制的访问

作者简介

E. Bolotova

Kuban State Medical University

Email: bolotowa_e@mail.ru
Dr. Sci. (Med.), Professor at the Department of Therapy №. 1, Faculty of Advanced Training and Postgraduate Education of Specialists Krasnodar, Russia

A. Dudnikova

Kuban State Medical University

Email: avdudnikova@yandex.ru
Cand. Sci. (Med.), Cardiologist, Therapist of the Highest Qualification Category, Consultative and Diagnostic Department, Clinic Krasnodar, Russia

I. Kiyanitskaya

Kuban State Medical University

Email: irina.kulabuhova@yandex.ru
Teaching Assistant at the Department of Faculty Therapy Krasnodar, Russia

参考

  1. Cusumano A.M., Rosa-Diez G.J., Gonzalez-Bedat M.C. Latin American Dialysis and Transplant Registry: Experience and contributions to end-stage renal disease epidemiology. World J. Nephrol. 2016;5(5):389-97.
  2. Zhang Y, Chang Y, Ryu S., et al. Thyroid hormone levels and incident chronic kidney disease in euthyroid individuals: the Kangbuk Samsung Health Study. Int. J. Epidemiol. 2014;43(5):1624-32. doi: 10.1093/ije/dyu126. PMID: 25011453.
  3. Muneer R., Naqvi S.A.A., Gul O., Zaidi S.D.H., Dar M.I. Thyroid and Heart: Severe Three Vessel Coronary Artery Disease in a Middle-Aged Female with Hypothyroidism. Cureus. 2019;11(11):e6095. doi: 10.7759/cureus.6095.
  4. Taylor P.N., Albrecht D., Scholz A., et al.Global epidemiology of hyperthyroidism and hypothyroidism. Nat. Rev. Endocrinol. 2018;14:301-16.
  5. Santos P.S., Llavero V.M., Brugos-Larumbe A., et al. Prevalence of thyroid dysfunction in a Large Southern European Population. Analysis of modulatory factors. The APNA study. Clin. Endocrinol. (Oxf). 2018;89(3):367-75. doi: 10.1111/cen.13764.
  6. Seo C., Kim S., Lee M., et al. Thyroid hormone replacement reduces the risk of cardiovascular diseases in diabetic nephropathy patients with subclinical hypothyroidism. Endocrin. Pract. 2018; 24(3): 265-72.
  7. Вербовой А.Ф., Шаронова Л.А., Косарева О.В. Состояние сердечно-сосудистой системы при гипотиреозе. Клин. медицина. 2016;94(7):497-503
  8. Jabbar A., Pingitore A., Pearce S.H., et al. Thyroid hormones and cardiovascular disease. Nat. Rev. Cardiol. 2017;14:39-55.
  9. Пащенко Е.В., Чесникова А. И., Терентьев В.П. Структурно -функциональные особенности левого желудочка у пациентов с сердечной недостаточностью при ишемической болезни сердца и тиреотоксикозе. Кубанский научный медицинский вестник. 2018;25(4):68-74.
  10. Torkian P., Mansournia M.A., Mansournia, N. Evaluation of biochemical markers of kidney function in patients with subclinical hypothyroidism in comparison with euthyroid people. J. Fam. Med. Prim. Care. 2020;9(8):4234-39. doi: 10.4103/jfmpc.jfmpc_757_20.
  11. Shin D.H., Lee M.J., Lee H.S., et al. Thyroid hormone replacement therapy attenuates the decline of renal function in chronic kidney disease patients with subclinical hypothyroidism. Thyroid: off. J. Am. Thyroid Assoc. 2013;23(6): 654-61. Doi. 10.1089/thy.2012.0475.
  12. Wang K., Xie K.,.Gu L., et al. Association of Thyroid Function With the Estimated Glomerular Filtration Rate in a Large Chinese Euthyroid Population. Kidney Blood Press. Res. 2018;43:1075-83.
  13. Chaker L., Sedaghat S., Hoorn E.J., et al. Association of thyroid function and risk of decreased kidney function: a population-based cohort study. Eur. J. 2016;175:653-60.
  14. Patil V.P., Shilpasree A.S., Patil V.S., et al. Evaluation of renal function in subclinical hypothyroidism. J. Lab. Phys. 2018;10(1):50-5. Doi: 10.4103/ JLP.JLP_67_17.
  15. Chang Y.C., Chang C.H., Yeh Y.C., et al. Subclinical and overt hypothyroidism is associated with reduced glomerular filtration rate and proteinuria: a large cross-sectional population study. Sci. Report. 2013;8(1):2031. Doi: 10.1038/ s41598-018-19693-4.
  16. Chaker L., et al. The association of thyroid function and the risk of kidney function decline: a population-based cohort study. Eur. J. Endocrinol. 2016;175(6):653-60.
  17. Schanz M., Pannes D., Dippon J., et al. The Influence of Thyroid Function, Inflammation, and Obesity on Risk Prediction of Acute Kidney Injury by Cystatin C in the Emergency Department. Kidney Blood Press Res. 2016;41:604-13.
  18. Schultheiss U.T., Daya N., Grams M.E., et al. Thyroid function, reduced kidney function and incident chronic kidney disease in a community-based population: the Atherosclerosis Risk in Communities study. Nephrol. Dial. Transplant. 2017;32:1874-81.
  19. Kannan L., Shaw P.A., Morley M.P., et al. Thyroid Dysfunction in Heart Failure and Cardiovascular Outcomes. Circ. Heart Fail. 2018;11(12):e005266.
  20. Sato Yu., et al. Subclinical Hypothyroidism Is Associated With Adverse Prognosis in Heart Failure Patients. Canad. J. Cardiol. 2017;34(80):87.
  21. Iglesias P., Bajo M.A., Selgas R., Di'ez J.J. Thyroid dysfunction and kidney disease: An update. Rev. Endocr. Metab. Disord. 2017;18(1):131-44.
  22. Weerakkody R.M., Lokuliyana PN. Severe hypothyroidism presenting as reversible proteinuria: two case reports. J. Med. Case Rep. 2019;28;13(1):270. doi: 10.1186/s13256-019-2216-3.
  23. Sonmez E., Bulur O., Ertugrul D. T., Sahin K., Beyan E., Dal K. Hyperthyroidism influences renal function. Endocrine. 2019;65(1):144-48. doi: 10.1007/s12020-019-01903-2.
  24. Bulur O., Dal K., Ertugrul D.T., et al. Renal function improves with the treatment of hypothyroidism. Endocr. Res. 2017;42(3):246-51. doi: 10.1080/07435800.2017.1293686.
  25. Sanai T., Nagashima A., Okamura K., et al. Thyroid function in patients on continuous ambulatory peritoneal dialysis in comparison with chronic kidney disease. Clin. Nephrol. 2018;89(3):181-86. doi: 10.5414/CN109228.
  26. Wang K, Xie K, Gu L, et al. Association of Thyroid Function With the Estimated Glomerular Filtration Rate in a Large Chinese Euthyroid Population. Kidney Blood Press Res. 2018;43:1075-83.
  27. Волкова А.Р., Дыгун О.Д., Лукичев Б.Г., Дора С.В., Галкина О.В. Дисфункция щитовидной железы при хронической болезни почек: состояние проблемы и пути решения. Нефрология. 2018;22(4):40-9. doi: 10.24884/1561-6274-2018-22-4-40-49.
  28. Скаржинская Н.С., Чесникова А.И., Сафроненко В.А. Особенности артериальной гипертензии у больных гипотиреозом, пути медикаментозной коррекции. Артериальная гипертензия. 2016;22(4):402-13
  29. Muneer R., Naqvi S.A.A., Gul O., Zaidi S.D.H., Dar M.I. Thyroid and Heart: Severe Three Vessel Coronary Artery Disease in a Middle-Aged Female with Hypothyroidism. Cureus. 2019;11(11):e6095. doi: 10.7759/cureus.6095.
  30. Канавец Н.С., Левина Л.И., Василенко В.С. Структурно-функциональное состояние артерий у женщин с метаболическим синдромом, ассоциированным с аутоиммунным тиреоидитом. Педиатр. 2016:7(4):90-4
  31. Li amis G, Filipp at os T.D., Liontos A., et al. Management Of Endocrine Disease: Hypothyroidism-associated hyponatremia: mechanisms, implications and treatment. Eur. J. Endocrinol. 2017;176(1):R15-20. doi: 10.1530/EJE-16-0493.
  32. Nagata T., Nakajima S., Fujiya A., Sobajima H., Yamaguchi M. Prevalence of hypothyroidism in patients with hyponatremia: A retrospective crosssectional study. PLoS. One. 2018;11;13(10):e0205687. doi: 10.1371/journal. pone.0205687.
  33. Ylli D., Klubo-Gwiezdzinska J., Wartofsky L. Thyroid emergencies. Pol. Arch. Intern. Med. 2019;129(7-8):526-34. doi: 10.20452/pamw.14876.
  34. Daimon M., Kato T., Kaino W., et al. Thyroid dysfunction in patients treated with tyrosine kinase inhibitors, sunitinib, sorafenib and axitinib, for metastatic renal cell carcinoma. Jpn. J. Clin. Oncol. 2012;42(8):742-47. Doi: 10.1093/ jjco / hys076.
  35. Cavalieri S., Cosmai L., Genderini A., et al. Lenvatinib-induced renal failure: two first-time case reports and review of literature. Expert. Opin Drug Metab. Toxicol. 2018;14(4):379-85. doi: 10.1080/17425255.2018.1461839.
  36. Вербовой А.Ф., Шаронова Л.А., Косарева О.В. Состояние сердечно-сосудистой системы при гипотиреозе. Клин. медицина. 2016;94, (7):497-503
  37. Попова Е., Тиньков А., Якубовская А. Механизм влияния тиреоидных гормонов на обмен холестерина. Врач. 2017;5:66-9
  38. Sigal G.A., Tavoni T.M., Silva B.M.O., et al. Effects of Short-Term Hypothyroidism on the Lipid Transfer to High-Density Lipoprotein and Other Parameters Related to Lipoprotein Metabolism in Patients Submitted to Thyroidectomy for Thyroid Cancer. Thyroid. 2019;29(1):53-8. Doi: 10.1089/ thy.2018.0190.
  39. Afsar B., Yilmaz M.I., Siriopol D., et al. Thyroid function and cardiovascular events in chronic kidney disease patients. J. Nephrol. 2017;30(2):235-42. doi: 10.1007/s40620-016-0300-y.
  40. Bonde Y., Plosch T., Kuipers F., Angelin B., Rudling M. Stimulation of murine biliary cholesterol secretion by thyroid hormone is dependent on a functional ABCG5/G8 complex. Hepatol. 2012;56(5):1828-37. doi: 10.1002/hep.25861.
  41. Liamis G., Filippatos T.D., Liontos A., Elisaf M.S. Hypothyroidism-associated hyponatremia: Mechanisms, implications and treatment. Eur. J. Endocrinol. 2017;176:15-20.
  42. Prevalence of hypertension and other cardiovascular riskfactors in subjects with subclinical hypothyroidism. Lidia Gonzalez Gil, Alejandro de la Sierra. Med. Clin. (English Edition). 2017;148(8):351-53.
  43. Punda A., Skrabic V., Torlak V., et al. Thyroid hormone levels are associated with metabolic components: a cross-sectional study. Croatian Med. J. 2020;61(3):230-38. Doi. 10.3325/cmj.2020.61.230.
  44. Giordano C., Karasik O., King-Morris K., Asmar A. Uric Acid as a Marker of Kidney Disease: Review of the Current Literature. Dis Markers. 2015;2015:382918. doi: 10.1155/2015/382918.
  45. Daimon M., Kato T., Kaino W., et al. Thyroid dysfunction in patients treated with tyrosine kinase inhibitors, sunitinib, sorafenib and axitinib, for metastatic renal cell carcinoma. Jpn. J. Clin. Oncol. 2012;42(8):742-77. Doi: 10.1093/ jjco / hys076.
  46. Cavalieri S., Cosmai L., Genderini A., et al. Lenvatinib-induced renal failure: two first-time case reports and review of literature. Expert. Opin Drug Metab. Toxicol. 2018;14(4):379-85. doi: 10.1080/17425255.2018.1461839.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##